medigraphic.com
SPANISH

Neurología, Neurocirugía y Psiquiatría

ISSN 0028-3851 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2006, Number 3

Next >>

Rev Neurol Neurocir Psiquiat 2006; 39 (3)

Early diagnostic for dementia in pacients with Parkinson’s disease through brain’s SPECT

Blaisdell-Vidal C, Carrasco-Vargas H, Gutiérrez-García Z, Elorriaga-Santiago S
Full text How to cite this article

Language: Spanish
References: 8
Page: 95-99
PDF size: 49.55 Kb.


Key words:

Evaluation, dementia, Parkinson’s disease, SPECT.

ABSTRACT

Background. Parkinson’s disease is associated with cognitive disorders. It has been said that a subcortical dementia can be found in up to 30% of the pacients. In order to investigate these symptoms, SPECT has demonstrated hypoperfusion in the hypocamus, putamen and frontal areas, which has been associated with this disorder.
Objetives. Performing SPECT to these patients, we will determinate the level of perfusion to the basal ganglia and the hypocampus and its correlation with standard neuropsychological tests (Barcelona and Mini mental state exam).
Methods. This is a transversal and open study, developed at the Hospital Central Militar, six weeks long, incluiding patiens that have been followed up at the Neurology clinic of the Hospital.
Results. Thirteen patients finished the study. The Barcelona test showed that 100% of them had memory problems. Eleven patiens (84%) had hypocampus defects, one patient (7%) hemispheric hypoperfusion and three (23%) with lobar hypoperfusion (frontoparietal).
Conclusions. SPECT demonstrated brain hypoperfusion at the hypocampus, frontal and temporal lobes, all of which had been probed to be affected by the Barcelona test. This makes SPECT usefull in the early stages of Parkinson’s disease to evaluate for subcortical dementia because of its sensibility to show perfusion defects in memory specific areas.


REFERENCES

  1. Álvarez GL, Sánchez CC, Álvarez GE. SPECT en la enfermedad de Parkinson y otros trastornos del movimiento. Rev Mex Neurociencia 2001; 2: 169-75.

  2. Peña CJ, Guardia J, Bertran SI, Manero RM, Jarne A. Versión abreviada del test Barcelona, (I): subtests y perfiles normales. Neurología 1997; 12: 99-111.

  3. Mohs RC, Rosen WG, Davis KL. “The Alzheimer’s Disease Assessment Scale: an instrument for assessing treatment efficacy”. Psychofarmacol Bull 1983; 19: 448-50.

  4. Lees A, Smith E. Cognitive deficits in the early stages of Parkinson’s disease. Brain 1983; 106: 257-70.

  5. Elizan T, Sroka H, Maker H, Smith H, Yahr M. Dementia in idiophatic Parkinson’s disease. J Neural Trans 1986; 65: 285-302.

  6. Cedarbaum J, Gancher S, Levin B, Tomer R, Rey G. Cognitive impairments in Parkinson’s disease. Neurologic Clin 1992; 10(2): 471-85.

  7. Kokmen E, Chandra V, Schoenberg BS. Trends in incidence of dementing illness in Rochester, Minnesota, in three quinquennial periods, 1960-1974. Neurology 1988; 975-80.

  8. Marsden CD, Harrison MJG. Outcome of investigation of patients with senile dementia. Br Med J 1972; 2: 249-52.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Neurol Neurocir Psiquiat. 2006;39